Skip to Main Content
All Podcasts

Adolescents and Young Adults with Sickle Cell Disease

Transcript

  • 00:00 --> 00:03Funding for Yale Cancer Answers is provided
  • 00:03 --> 00:07by Smilow Cancer Hospital and AstraZeneca.
  • 00:07 --> 00:09Welcome to Yale Cancer Answers with
  • 00:09 --> 00:12your host doctor Anees Chagpar.
  • 00:12 --> 00:14Yale Cancer Answers features the latest
  • 00:14 --> 00:16information on cancer care by welcoming
  • 00:16 --> 00:19oncologists and specialists who are on the
  • 00:19 --> 00:21forefront of the battle to fight cancer.
  • 00:21 --> 00:24This week it's a conversation about the care
  • 00:24 --> 00:26of adolescents and young adults with sickle
  • 00:26 --> 00:28cell disease with Doctor Cece Calhoun.
  • 00:28 --> 00:31Dr Calhoun is an assistant professor of
  • 00:31 --> 00:33medicine and hematology and assistant
  • 00:33 --> 00:35professor of Pediatrics in hematology
  • 00:35 --> 00:38oncology at the Yale School of Medicine,
  • 00:38 --> 00:41where Doctor Chagpar is a
  • 00:41 --> 00:43professor of surgical oncology.
  • 00:43 --> 00:45Cece, maybe we could start off by
  • 00:45 --> 00:47you telling us a little bit about
  • 00:47 --> 00:49yourself and what you do.
  • 00:49 --> 00:52I like to call myself a lifespan
  • 00:52 --> 00:54hematologist, and both my clinical
  • 00:54 --> 00:57and research interests center around
  • 00:57 --> 00:59the care of young adults with sickle
  • 00:59 --> 01:01cell disease as they transition
  • 01:01 --> 01:04from pediatric to adult care.
  • 01:04 --> 01:05We know it's a really high
  • 01:05 --> 01:06risk time for them.
  • 01:06 --> 01:08And so all the work that I do both in
  • 01:08 --> 01:10the clinic and in the research setting
  • 01:10 --> 01:12is about making that process better.
  • 01:12 --> 01:15Is sickle cell disease a cancer?
  • 01:15 --> 01:16Tell us more about what
  • 01:16 --> 01:18exactly sickle cell disease is
  • 01:18 --> 01:21and why it's being seen
  • 01:21 --> 01:23by an oncologist?
  • 01:23 --> 01:25That's a great question, so actually sickle
  • 01:25 --> 01:28cell disease is an inherited condition
  • 01:28 --> 01:31of the red blood cells and so many
  • 01:31 --> 01:33people are familiar with anemia
  • 01:33 --> 01:36and conditions of that sort,
  • 01:36 --> 01:37which affect red blood
  • 01:37 --> 01:38cells and hemoglobin.
  • 01:38 --> 01:41And that's what sickle cell disease is
  • 01:41 --> 01:43a condition of, and it's genetic.
  • 01:43 --> 01:45So patients are born with it,
  • 01:45 --> 01:47and what it manifests as is a normal
  • 01:47 --> 01:49red blood cells are kind of squishy.
  • 01:49 --> 01:52I like to think of them as Jelly
  • 01:52 --> 01:53doughnuts because I like food.
  • 01:53 --> 01:55But when you have sickle cell disease
  • 01:55 --> 01:56because of a genetic mutation
  • 01:56 --> 01:58your red blood cells
  • 01:58 --> 02:00are not squishy and malleable,
  • 02:00 --> 02:02they can be really stiff
  • 02:02 --> 02:04and misshapen like a sickle.
  • 02:04 --> 02:06They can be shaped like a sickle or a banana,
  • 02:06 --> 02:08and so if you think of
  • 02:08 --> 02:09your blood cells as pipes,
  • 02:09 --> 02:11imagine if you had your Jelly doughnuts
  • 02:11 --> 02:14kind of going through those pipes,
  • 02:14 --> 02:15bouncing off the walls,
  • 02:15 --> 02:17taking oxygen to where it needs to go,
  • 02:17 --> 02:19and you replace those cells
  • 02:19 --> 02:20with sticky stuff,
  • 02:20 --> 02:22fragile misshapen red blood cells like
  • 02:22 --> 02:24sickle cells that are scratching up
  • 02:24 --> 02:26the red blood vessels sticking together,
  • 02:26 --> 02:28causing blockages, impeding flow,
  • 02:28 --> 02:30and then you can imagine all
  • 02:30 --> 02:32the complications that patients
  • 02:32 --> 02:34with sickle cell face.
  • 02:34 --> 02:38Most saliently or what patients have
  • 02:38 --> 02:41to really deal with is a lot of pain.
  • 02:41 --> 02:42That's the thing that brings
  • 02:42 --> 02:43them to the hospital.
  • 02:43 --> 02:46And acute meaning an unplanned basis,
  • 02:46 --> 02:48but any part of our body where
  • 02:48 --> 02:49there are blood vessels,
  • 02:49 --> 02:50those misshapen
  • 02:50 --> 02:52cells can get clogged up in those
  • 02:52 --> 02:55blood vessels and cause problems.
  • 02:55 --> 02:56It's important for patients
  • 02:56 --> 02:58with sickle cell disease to have
  • 02:58 --> 03:00regular care by an oncologist
  • 03:00 --> 03:02who also understands hematology,
  • 03:02 --> 03:04the blood, to make sure that all their
  • 03:04 --> 03:06organs are in tip top condition
  • 03:06 --> 03:08and that we treat anything before
  • 03:08 --> 03:09there's a problem.
  • 03:09 --> 03:12Now, I would think that if
  • 03:12 --> 03:14you're a pediatric patient and
  • 03:14 --> 03:17this is an inherited condition,
  • 03:17 --> 03:19you might have a sense of whether or
  • 03:19 --> 03:21not you have sickle cell disease
  • 03:21 --> 03:24based on whether your parents did.
  • 03:24 --> 03:26But somebody had to start with the
  • 03:26 --> 03:29genetic mutation to begin with.
  • 03:29 --> 03:30So how many of your patients
  • 03:30 --> 03:32actually know that they have sickle
  • 03:32 --> 03:34cell disease from the time that
  • 03:34 --> 03:36they were born
  • 03:36 --> 03:39and how many of them present to you acutely?
  • 03:41 --> 03:43In the United
  • 03:43 --> 03:46States we have the benefit of the newborn
  • 03:46 --> 03:49screen that all babies born in hospitals,
  • 03:49 --> 03:50when they
  • 03:50 --> 03:52get their heel poked and get that
  • 03:52 --> 03:54little spot of blood that can test
  • 03:54 --> 03:56for a variety of genetic conditions
  • 03:56 --> 03:58and sickle cell disease is
  • 03:58 --> 03:59included in those conditions.
  • 03:59 --> 04:02So if a child has an abnormal newborn screen,
  • 04:02 --> 04:04oftentimes the pediatrician will
  • 04:04 --> 04:07refer them to a hematologist for
  • 04:07 --> 04:09further evaluation and work up.
  • 04:09 --> 04:11And sometimes, even if it's abnormal
  • 04:11 --> 04:14to show sickle cell trait,
  • 04:14 --> 04:16which means that you don't have the disease,
  • 04:16 --> 04:18but you can be a carrier,
  • 04:18 --> 04:19and if your partner has the disease,
  • 04:19 --> 04:21you can have a child with sickle
  • 04:21 --> 04:21cell disease.
  • 04:21 --> 04:23We can figure that out from
  • 04:23 --> 04:24the newborn screen.
  • 04:24 --> 04:27So these days we know pretty early on
  • 04:27 --> 04:29which is critical to the survival
  • 04:29 --> 04:32of our young children or infants and
  • 04:32 --> 04:34toddlers and in other countries
  • 04:34 --> 04:37the newborn screen isn't quite as universal,
  • 04:37 --> 04:39and so sometimes children could present
  • 04:39 --> 04:41with swelling of the hands and feet.
  • 04:41 --> 04:43That's something called dactylitis,
  • 04:43 --> 04:46which is pretty rare these
  • 04:46 --> 04:48days as a presenting sign.
  • 04:48 --> 04:50And then there's some patients with more
  • 04:50 --> 04:53milder forms of sickle cell disease
  • 04:53 --> 04:55that don't know until they're older
  • 04:55 --> 04:56children or young adults,
  • 04:56 --> 04:59but most of the time we get them in
  • 04:59 --> 05:01our catchment when they are young
  • 05:01 --> 05:02because of their newborn screen and
  • 05:02 --> 05:04can really wrap our arms around them
  • 05:04 --> 05:06and give them the care they need.
  • 05:06 --> 05:08Let's suppose you're a newborn baby and
  • 05:08 --> 05:11you had your heel poked and they tell
  • 05:11 --> 05:13you that you have sickle cell disease.
  • 05:13 --> 05:15Well, presumably they don't tell you
  • 05:15 --> 05:18they tell your parents and you get
  • 05:18 --> 05:19referred to a pediatric oncologist.
  • 05:19 --> 05:22If that means that your red blood
  • 05:22 --> 05:24cells are now more
  • 05:24 --> 05:26like bananas than squishy Jelly
  • 05:26 --> 05:29Donuts, what can you do about that?
  • 05:29 --> 05:30I mean, is it reversible?
  • 05:31 --> 05:33At this time the only cure for sickle
  • 05:33 --> 05:35cell disease or way to reverse
  • 05:35 --> 05:37those cells is by replacing your
  • 05:37 --> 05:39bone marrow with another persons,
  • 05:39 --> 05:41but that's pretty rare.
  • 05:41 --> 05:43Later in the show, you get to talk
  • 05:43 --> 05:45a little bit more about therapies
  • 05:45 --> 05:47coming down the pipeline for patients,
  • 05:47 --> 05:49but right now that's the only
  • 05:49 --> 05:51way to reverse.
  • 05:51 --> 05:53However, if you are a little baby
  • 05:53 --> 05:54and your parents find out that
  • 05:54 --> 05:56you have sickle cell disease
  • 05:56 --> 05:58the benefit of coming and talking
  • 05:58 --> 06:00to a pediatric oncologist and
  • 06:00 --> 06:02hematologist who knows about this
  • 06:02 --> 06:04is that you now have a team member,
  • 06:04 --> 06:05somebody on your team that
  • 06:05 --> 06:06can help your baby,
  • 06:07 --> 06:08or you if you're the baby,
  • 06:08 --> 06:09stay healthy and safe.
  • 06:09 --> 06:12And what that looks like as a
  • 06:12 --> 06:15toddler is getting them started on
  • 06:15 --> 06:16penicillin prophylactically or in
  • 06:16 --> 06:18advance before there's any problems
  • 06:18 --> 06:21because we found that as
  • 06:21 --> 06:25recently as the late 70s,
  • 06:25 --> 06:26there was kind of a peak
  • 06:26 --> 06:29in infancy and toddlerhood of death,
  • 06:29 --> 06:31because patients with sickle cell
  • 06:31 --> 06:32were getting really bad infections,
  • 06:32 --> 06:34but we found that if we vaccinate them
  • 06:34 --> 06:36and give them prophylactic penicillin,
  • 06:36 --> 06:38they live well into adulthood.
  • 06:38 --> 06:39The challenge becomes,
  • 06:39 --> 06:41how do we help them when they
  • 06:41 --> 06:42go from infant to adults?
  • 06:42 --> 06:43And that's what I work on in my work.
  • 06:44 --> 06:46So just to back up a little bit when
  • 06:46 --> 06:49you say prophylactic penicillin,
  • 06:49 --> 06:51do you mean like every day for
  • 06:51 --> 06:52the rest of their life?
  • 06:53 --> 06:55So definitely every day for the
  • 06:55 --> 06:58first five years of their life.
  • 06:58 --> 07:00But what it does is it
  • 07:00 --> 07:02protects them against really bad
  • 07:02 --> 07:05infections like pneumococcus you know
  • 07:05 --> 07:07patients with sickle cell disease,
  • 07:07 --> 07:09their spleen doesn't really work
  • 07:09 --> 07:11as well as somebody without sickle
  • 07:11 --> 07:13cell and because of that they are
  • 07:13 --> 07:15susceptible to certain types of
  • 07:15 --> 07:17infections and that penicillin
  • 07:17 --> 07:19every day just like a vitamin helps
  • 07:19 --> 07:21them to stay healthy and safe.
  • 07:21 --> 07:24So why is there this transition then
  • 07:24 --> 07:26from childhood to young adulthood?
  • 07:26 --> 07:28What's the difference in terms of
  • 07:28 --> 07:30the disease and how it's managed
  • 07:30 --> 07:31that requires a specialist like you?
  • 07:33 --> 07:36Well, I think it's a variety of things.
  • 07:36 --> 07:37It's not just the disease,
  • 07:37 --> 07:39but it's becoming a young person
  • 07:39 --> 07:41and learning how to navigate the
  • 07:41 --> 07:43health care system on your own
  • 07:43 --> 07:44and earlier we talked
  • 07:44 --> 07:46about newborns and
  • 07:46 --> 07:48if you were a newborn and found out
  • 07:48 --> 07:51you had sickle cell disease that your parents
  • 07:51 --> 07:53would help you take you to the doctor.
  • 07:53 --> 07:54Manage your care,
  • 07:54 --> 07:56give you that prophylactic penicillin.
  • 07:56 --> 07:57But the beautiful part about being
  • 07:57 --> 07:59a young adult is you can start to
  • 07:59 --> 08:01assume some of that care for yourself,
  • 08:01 --> 08:02so it's pretty
  • 08:02 --> 08:04multi Factorial is a word I always
  • 08:05 --> 08:07like to use and I like to
  • 08:07 --> 08:10think that I was a pretty smart young
  • 08:10 --> 08:12adult like I made some good decisions.
  • 08:12 --> 08:13I'm a doctor now,
  • 08:13 --> 08:15but I still did some foolish things
  • 08:15 --> 08:17as a 16-17 eighteen year old and
  • 08:17 --> 08:19that's without a chronic disease.
  • 08:19 --> 08:21So in sickle cell disease,
  • 08:21 --> 08:23what we can do as lifespan hematologists
  • 08:23 --> 08:25and as health care providers is
  • 08:25 --> 08:27really help our patients as their
  • 08:27 --> 08:29disease complications may become
  • 08:29 --> 08:31a little more severe as they're
  • 08:31 --> 08:33learning to manage themselves.
  • 08:33 --> 08:35As they're learning to navigate a
  • 08:35 --> 08:37pretty complex health care system,
  • 08:37 --> 08:39and as they're just trying to be productive,
  • 08:39 --> 08:40happy young adults.
  • 08:42 --> 08:44What kinds of things do you
  • 08:44 --> 08:46talk about with your patients?
  • 08:46 --> 08:47It sounds like
  • 08:47 --> 08:49after their five years old,
  • 08:49 --> 08:51they're no longer on penicillin,
  • 08:51 --> 08:53but there's still no way to reverse
  • 08:53 --> 08:55the condition, so you're still
  • 08:55 --> 08:58at risk of all of those sticky,
  • 08:58 --> 08:59misshapen blood cells forming
  • 08:59 --> 09:01clots all over your body,
  • 09:01 --> 09:03which presumably can cause
  • 09:03 --> 09:04all kinds of problems.
  • 09:04 --> 09:07Is it just a matter
  • 09:07 --> 09:09of telling your patients what to
  • 09:09 --> 09:12watch for and when to seek help?
  • 09:12 --> 09:15Or are there things that they can do
  • 09:15 --> 09:18to reduce the risk of clots and
  • 09:18 --> 09:21other problems that it can cause?
  • 09:21 --> 09:23Absolutely, so I want to answer
  • 09:23 --> 09:26your question in two parts.
  • 09:26 --> 09:28First, what other parts of the
  • 09:28 --> 09:30body does sickle cell affect?
  • 09:30 --> 09:33How does that show up for
  • 09:33 --> 09:35patients across their lives?
  • 09:35 --> 09:38One of the things that our patients most
  • 09:38 --> 09:41deal with is pain every single day.
  • 09:41 --> 09:43So when those blood vessels get clogged
  • 09:43 --> 09:45up by those sickle cells and those juicy
  • 09:45 --> 09:47Jelly doughnut cells can't get through,
  • 09:47 --> 09:48that means oxygen isn't
  • 09:48 --> 09:50going to where it needs to
  • 09:50 --> 09:51in our bodies.
  • 09:51 --> 09:52And because of that,
  • 09:52 --> 09:54that can result in pretty bad bone pain
  • 09:54 --> 09:56for patients with sickle cell disease,
  • 09:56 --> 09:59and this is the thing that really affects
  • 09:59 --> 10:01their quality of life as young students
  • 10:01 --> 10:03trying to learn and keep up in school.
  • 10:03 --> 10:04If you have to be admitted to
  • 10:04 --> 10:05the hospital several times
  • 10:05 --> 10:08a year you can imagine how
  • 10:08 --> 10:11frustrating that can be as a scholar.
  • 10:11 --> 10:13Other parts of the body that are affected
  • 10:13 --> 10:15by sickle cell disease are numerous.
  • 10:15 --> 10:16Though patients with sickle
  • 10:16 --> 10:18cell disease can have something
  • 10:18 --> 10:19called acute chest syndrome,
  • 10:19 --> 10:21which is a really bad infection of the
  • 10:21 --> 10:23lungs that can be very challenging,
  • 10:23 --> 10:27they can even have strokes as young people,
  • 10:27 --> 10:28which is one of the reasons that
  • 10:28 --> 10:30compelled me as a Med student to
  • 10:30 --> 10:32pursue hematology was seeing a sickle
  • 10:32 --> 10:34cell patient eight years old who had
  • 10:34 --> 10:36a stroke in Pediatrics.
  • 10:36 --> 10:38And in order to kind of get a jump on these things,
  • 10:38 --> 10:40we do several things,
  • 10:40 --> 10:41we do screenings.
  • 10:41 --> 10:43Something called a transcranial Doppler,
  • 10:43 --> 10:45which is basically like an ultrasound
  • 10:45 --> 10:47of your head where you can look at the
  • 10:47 --> 10:48blood vessels and make sure you're
  • 10:48 --> 10:50not at risk for having a stroke.
  • 10:50 --> 10:53We always make sure that our patients
  • 10:53 --> 10:56have their eyes checked because
  • 10:56 --> 10:57sometimes in sickle cell disease
  • 10:57 --> 11:00you can have vision changes and a
  • 11:00 --> 11:02regular follow up with a hematologist
  • 11:02 --> 11:04can help you notice any changes
  • 11:04 --> 11:06before they cause problems.
  • 11:06 --> 11:08One of the biggest things and one
  • 11:08 --> 11:10of the things we know works and
  • 11:10 --> 11:11helps prolong life
  • 11:11 --> 11:13in sickle cell patients is a use of
  • 11:13 --> 11:15a medication called Hydroxyurea.
  • 11:15 --> 11:18Now, some of your listeners may be familiar,
  • 11:18 --> 11:21because sometimes this can be used in
  • 11:21 --> 11:24patients who have certain cancer diagnosis,
  • 11:24 --> 11:26but in sickle cell disease,
  • 11:26 --> 11:28the dose that we use is much lower and the
  • 11:28 --> 11:30way that we use it as a bit different.
  • 11:30 --> 11:32And we know that it kind of helps
  • 11:32 --> 11:35you have more juicy fat
  • 11:35 --> 11:37cells then bananas and so your body
  • 11:37 --> 11:39overall does better in the long term.
  • 11:41 --> 11:43So just to follow up on a few
  • 11:43 --> 11:45things that you just said.
  • 11:45 --> 11:47First off taking that last
  • 11:47 --> 11:49comment about Hydroxyurea making
  • 11:49 --> 11:52You have more fat and juicy like
  • 11:52 --> 11:54blood cells rather than sickling bananas,
  • 11:54 --> 11:57is it true that if you
  • 11:57 --> 11:59have sickle cell disease,
  • 11:59 --> 12:01not all of your blood cells are
  • 12:01 --> 12:03bananas and it is possible to
  • 12:03 --> 12:05increase the number of Jelly doughnut
  • 12:05 --> 12:07blood cells that you have instead
  • 12:07 --> 12:09of bananas?
  • 12:10 --> 12:13Absolutely, and that is up until
  • 12:13 --> 12:16recently, the only FDA
  • 12:16 --> 12:18approved medication that we have had
  • 12:18 --> 12:19for our patients is Hydroxyurea
  • 12:19 --> 12:22to increase the amount of non sickle cells,
  • 12:22 --> 12:25Jelly doughnut cells and ensure that
  • 12:25 --> 12:27you're pain complications are lower
  • 12:27 --> 12:30and that your organs can really get
  • 12:30 --> 12:32the oxygen they need to thrive.
  • 12:32 --> 12:34So an obvious question is why
  • 12:34 --> 12:36not use more and make
  • 12:36 --> 12:39all of your blood cells Jelly Donuts?
  • 12:39 --> 12:40But hold that thought.
  • 12:40 --> 12:43Because first we need to take a short
  • 12:43 --> 12:46break for medical minute. Stay tuned
  • 12:46 --> 12:48to learn more about adolescents and
  • 12:48 --> 12:50young adults with sickle cell disease
  • 12:50 --> 12:52with my guest doctor CeCe Calhoun.
  • 12:52 --> 12:54Funding for Yale Cancer Answers
  • 12:54 --> 12:57comes from Smilow Cancer Hospital.
  • 12:57 --> 12:59Fifteen care centers offer access to
  • 12:59 --> 13:01oncologists committed to providing
  • 13:01 --> 13:03patients with cancer and blood diseases.
  • 13:03 --> 13:05Individualized innovative care.
  • 13:05 --> 13:08Find us. Milo Care Center near
  • 13:08 --> 13:10you at yalecancercenter.org.
  • 13:12 --> 13:15There are over 16.9 million
  • 13:15 --> 13:17cancer survivors in the US and
  • 13:17 --> 13:19over 240,000 here in Connecticut.
  • 13:19 --> 13:21Completing treatment for cancer
  • 13:21 --> 13:23is a very exciting milestone,
  • 13:23 --> 13:25but cancer and its treatment can
  • 13:25 --> 13:27be a life changing experience.
  • 13:27 --> 13:30The return to normal activities in
  • 13:30 --> 13:32relationships may be difficult and
  • 13:32 --> 13:33cancer survivors may face other
  • 13:33 --> 13:36long term side effects of cancer,
  • 13:36 --> 13:37including heart problems,
  • 13:37 --> 13:38osteoporosis,
  • 13:38 --> 13:41fertility issues and an increased
  • 13:41 --> 13:43risk of second cancers.
  • 13:43 --> 13:45Resources for cancer survivors are
  • 13:45 --> 13:47available at federally designated
  • 13:47 --> 13:49Comprehensive cancer centers
  • 13:49 --> 13:51such as the Yale Cancer Center
  • 13:51 --> 13:53and at Smilow Cancer Hospital to
  • 13:53 --> 13:55keep cancer survivors well and
  • 13:55 --> 13:57focused on healthy living.
  • 13:57 --> 13:59The Smilow Cancer Hospital Survivorship
  • 13:59 --> 14:01Clinic focuses on providing guidance
  • 14:01 --> 14:04and direction to empower survivors to
  • 14:04 --> 14:06take steps to maximize their health,
  • 14:06 --> 14:08quality of life and longevity.
  • 14:08 --> 14:11More information is available
  • 14:11 --> 14:12at yalecancercenter.org. You're
  • 14:12 --> 14:13listening to Connecticut
  • 14:13 --> 14:14Public Radio.
  • 14:15 --> 14:17Welcome back to Yale Cancer Answers.
  • 14:17 --> 14:19This is Doctor Anees Chagpar and I'm
  • 14:19 --> 14:22joined tonight by my guest Dr. Cece Calhoun.
  • 14:22 --> 14:25We're talking about the care of adolescents
  • 14:25 --> 14:27and young adults with sickle cell
  • 14:27 --> 14:29disease and bright before the break
  • 14:29 --> 14:32CeCe was mentioning that while sickle cell
  • 14:32 --> 14:35disease is completely
  • 14:35 --> 14:37irreversible,
  • 14:37 --> 14:40that actually using a drug called
  • 14:40 --> 14:43Hydroxyurea can help your body to
  • 14:43 --> 14:45create more of these quote juicy
  • 14:45 --> 14:48cells which are normal red blood cells
  • 14:48 --> 14:52and less of these quote banana like
  • 14:52 --> 14:54cells which are the sickle cells.
  • 14:54 --> 14:56So my question to you was.
  • 14:56 --> 15:01before we had the break, is why
  • 15:01 --> 15:03not just give more Hydroxyurea?
  • 15:03 --> 15:06I mean if it helps your body to produce
  • 15:06 --> 15:09more normal cells and less sickle cells,
  • 15:09 --> 15:10wouldn't that be a way to kind
  • 15:10 --> 15:12of reverse it?
  • 15:13 --> 15:16I would love if it could be
  • 15:16 --> 15:17totally reversed by Hydroxyurea
  • 15:17 --> 15:19but we know that when our
  • 15:19 --> 15:21patients are awesome, take their
  • 15:21 --> 15:23medications every day as prescribed,
  • 15:23 --> 15:26there's still an upper limit to
  • 15:26 --> 15:29how many of those juicy fat
  • 15:29 --> 15:31cells they can replace.
  • 15:31 --> 15:33They can produce to replace the banana cells,
  • 15:33 --> 15:36so there's a threshold of how
  • 15:36 --> 15:38effective the drug can be,
  • 15:38 --> 15:39but it can really,
  • 15:39 --> 15:41really help enough to help
  • 15:41 --> 15:43your organs stay healthy.
  • 15:43 --> 15:46So this Hydroxyurea is something
  • 15:46 --> 15:48that you're taking every day?
  • 15:48 --> 15:49For your whole life?
  • 15:49 --> 15:52And the other thing
  • 15:52 --> 15:55that you mentioned before the break
  • 15:55 --> 15:59and I wanted to pick up on as well
  • 15:59 --> 16:02was this concept of pain and the fact
  • 16:02 --> 16:05that many of these patients they present
  • 16:05 --> 16:08with pain and they have pain every day
  • 16:08 --> 16:11which impairs their ability to
  • 16:11 --> 16:14concentrate at school or maybe place
  • 16:14 --> 16:18boards so what do you do about that?
  • 16:18 --> 16:20I mean, are these patients
  • 16:20 --> 16:22treated with daily painkillers?
  • 16:22 --> 16:24Or do you tell them to simply
  • 16:24 --> 16:26wait until they have pain and
  • 16:26 --> 16:28then prescribe pain medication?
  • 16:28 --> 16:31I mean how do they get through their day
  • 16:31 --> 16:33to day life if they're in pain everyday?
  • 16:34 --> 16:37Yeah, so sickle cell patients are warriors
  • 16:37 --> 16:41and you'll often see that described because
  • 16:41 --> 16:44despite having pain of variable severity,
  • 16:44 --> 16:47they managed to live life and be productive.
  • 16:47 --> 16:50That's one of the most awesome things
  • 16:50 --> 16:52about working with sickle cell patients.
  • 16:52 --> 16:55So in terms of pain prevention,
  • 16:55 --> 16:56what can we do?
  • 16:56 --> 16:58Number one Hydroxyurea and get more juicy
  • 16:58 --> 17:00cells around so you have less pain.
  • 17:00 --> 17:03And recently there are a couple
  • 17:03 --> 17:05of medications on the market
  • 17:05 --> 17:07that help with pain prevention.
  • 17:07 --> 17:10Also just keeping yourself well hydrated.
  • 17:10 --> 17:12My patients are so wonderful in
  • 17:12 --> 17:14that they often know their bodies.
  • 17:14 --> 17:15They know their triggers.
  • 17:15 --> 17:18And what situations make their pain worse.
  • 17:18 --> 17:19And what kind of things can
  • 17:19 --> 17:20make their pain better.
  • 17:20 --> 17:22So really being attuned to those things
  • 17:22 --> 17:25in terms of addressing pain acutely
  • 17:25 --> 17:28when it happens and it's not planned,
  • 17:28 --> 17:31we have a couple of things in our toolkit.
  • 17:31 --> 17:33Yes, pain medication is something
  • 17:33 --> 17:36that we give frequently for pain,
  • 17:36 --> 17:38but we can also use red
  • 17:38 --> 17:40blood cell transfusions if we need to.
  • 17:40 --> 17:43If somebody is having pain often,
  • 17:43 --> 17:46but many times we can't predict
  • 17:46 --> 17:47when the pain will come,
  • 17:47 --> 17:49or how severe it will be,
  • 17:49 --> 17:51and so because of that our patients
  • 17:51 --> 17:53have to get care in the ED sometimes
  • 17:53 --> 17:54to get treatment for their pain.
  • 17:55 --> 17:57You mentioned something
  • 17:57 --> 17:59that I found kind of intriguing.
  • 17:59 --> 18:01You said that we have medications
  • 18:01 --> 18:03for pain prevention, like what?
  • 18:04 --> 18:07Hot off the press I know,
  • 18:07 --> 18:09so recently there's been
  • 18:09 --> 18:11an FDA approved medication,
  • 18:11 --> 18:13Adakveo or crizanlizumab
  • 18:15 --> 18:18but I try not to say
  • 18:18 --> 18:20that because crizanlizumab,
  • 18:20 --> 18:23but that can be used to prevent pain
  • 18:23 --> 18:26as an infusion given once monthly.
  • 18:32 --> 18:33And another medication that's recently been
  • 18:33 --> 18:36approved is something called Oxbryta
  • 18:36 --> 18:38and really, what that does is increase
  • 18:38 --> 18:40patients with sickle cell disease,
  • 18:40 --> 18:41their hemoglobin,
  • 18:41 --> 18:44and so the thought is if their
  • 18:44 --> 18:46hemoglobin is better they
  • 18:46 --> 18:49may in turn have less pain,
  • 18:49 --> 18:51but the primary medication that
  • 18:51 --> 18:54is out there for pain
  • 18:54 --> 18:56prevention is Adakveo.
  • 18:57 --> 18:59That sounds like a
  • 18:59 --> 19:00pretty good deal, right?
  • 19:00 --> 19:02If instead of having pain everyday,
  • 19:02 --> 19:05if you had an infusion once a month,
  • 19:05 --> 19:07does that infusion kind of really get
  • 19:07 --> 19:09rid of the chances of having pain?
  • 19:09 --> 19:10Or not really?
  • 19:11 --> 19:14I think that the medication is pretty
  • 19:14 --> 19:17new and patients themselves are
  • 19:17 --> 19:19are individuals,
  • 19:19 --> 19:20and so I've had some patients
  • 19:20 --> 19:21who it's worked great for.
  • 19:21 --> 19:23I've had some patients that we
  • 19:23 --> 19:25just have to try other things.
  • 19:25 --> 19:27I think the wonderful thing
  • 19:27 --> 19:28about being a physician
  • 19:28 --> 19:30scientist and sickle cell,
  • 19:30 --> 19:32or even being a patient right now
  • 19:32 --> 19:33who has sickle cell is that it is
  • 19:33 --> 19:35such a fertile time for discovery.
  • 19:35 --> 19:37In terms of sickle cell disease,
  • 19:37 --> 19:38how to prevent complications
  • 19:38 --> 19:40and how to cure it.
  • 19:40 --> 19:42So you just have to work with
  • 19:42 --> 19:43your hematologist to find
  • 19:43 --> 19:45the right regimen for you.
  • 19:46 --> 19:48So I want to pick up on
  • 19:48 --> 19:50that discovery and some of the
  • 19:50 --> 19:52new advances that are going on
  • 19:52 --> 19:54in terms of sickle cell research.
  • 19:54 --> 19:56But before that I had one other question
  • 19:56 --> 19:58about the complications
  • 19:58 --> 20:01you had mentioned before the break.
  • 20:01 --> 20:04One of the impetuses for you to
  • 20:04 --> 20:05become a pediatric climatologist
  • 20:05 --> 20:08was an 8 year old who had a stroke,
  • 20:08 --> 20:12which just I mean is heartbreaking to me.
  • 20:12 --> 20:14But clearly if you think about these
  • 20:15 --> 20:17sickle cells, it makes sense, right?
  • 20:17 --> 20:18These sickle cells kind of glom
  • 20:18 --> 20:20together and they cut off blood
  • 20:20 --> 20:21supply to a part of your brain
  • 20:21 --> 20:22that's called the stroke.
  • 20:22 --> 20:25Now when we think about
  • 20:25 --> 20:26older patients who
  • 20:26 --> 20:29may be at risk of stroke or who may
  • 20:29 --> 20:31be at risk of heart attack or who
  • 20:31 --> 20:33may be at risk of other clotting,
  • 20:33 --> 20:35whether it's in their lungs or
  • 20:35 --> 20:37in their legs or whatever,
  • 20:37 --> 20:39we often use blood thinners,
  • 20:39 --> 20:41so are sickle cell patients put
  • 20:41 --> 20:44on blood thinners to
  • 20:44 --> 20:45prevent these complications?
  • 20:45 --> 20:46Since we know that they're
  • 20:46 --> 20:48at risk of getting clots.
  • 20:48 --> 20:51So the blockages that occur in sickle
  • 20:51 --> 20:54cell disease are a little bit different
  • 20:54 --> 20:56than your normal blood clot, which is
  • 20:56 --> 20:59caused by a different series of events,
  • 20:59 --> 21:02and so for patients with sickle cell disease,
  • 21:02 --> 21:03though they are at an increased
  • 21:03 --> 21:04risk to have those
  • 21:04 --> 21:07traditionally, what we think of blood clots,
  • 21:07 --> 21:09we don't put them on blood thinners
  • 21:09 --> 21:11to try to prevent complications
  • 21:11 --> 21:12with sickle cell disease.
  • 21:12 --> 21:14We know those blockages can be stuck
  • 21:14 --> 21:16like a clot, or they can be transient,
  • 21:16 --> 21:18they come and go because of the
  • 21:18 --> 21:19cells sticking together.
  • 21:19 --> 21:20It's not like the other proteins in
  • 21:20 --> 21:22your body are swimming over there,
  • 21:22 --> 21:23making a huge clot.
  • 21:23 --> 21:26What we do in our young people
  • 21:26 --> 21:28to maximize stroke prevention
  • 21:28 --> 21:30is we do screenings like the
  • 21:30 --> 21:31Transcranial Doppler I mentioned.
  • 21:31 --> 21:34And if we notice any kind
  • 21:34 --> 21:35of abnormality at all,
  • 21:35 --> 21:37we have a couple of options.
  • 21:37 --> 21:40One we can start them on chronic
  • 21:40 --> 21:43transfusion to decrease the
  • 21:43 --> 21:45amount of sickle cells circulating in their
  • 21:45 --> 21:48blood and give them more normal cells.
  • 21:48 --> 21:50Or if somebody has been
  • 21:50 --> 21:52on transfusions,
  • 21:52 --> 21:54their transcranial dopplers looks fine,
  • 21:54 --> 21:56we can switch them to again Hydroxyurea
  • 21:56 --> 21:59put more Jelly Donuts around,
  • 21:59 --> 22:00have less sickle cells,
  • 22:00 --> 22:02decrease the risk of complications,
  • 22:02 --> 22:04and that's again why it's important
  • 22:04 --> 22:05to connect with your
  • 22:05 --> 22:07friendly hematologist so we
  • 22:07 --> 22:09can help you on that journey.
  • 22:09 --> 22:11Yeah, but presumably you would have
  • 22:11 --> 22:13already been on the Hydroxyurea
  • 22:13 --> 22:16so if that transcranial Doppler finds
  • 22:16 --> 22:19that you're at increased risk
  • 22:19 --> 22:21I guess the transfusion
  • 22:21 --> 22:23is your only alternative,
  • 22:23 --> 22:26but the issue there is if you keep
  • 22:26 --> 22:28getting transfusions on a regular basis,
  • 22:28 --> 22:31doesn't that increase your risk of
  • 22:31 --> 22:33transfusion reactions and potentially
  • 22:33 --> 22:34ultimately developing antibodies such
  • 22:34 --> 22:37that there are fewer and fewer blood
  • 22:37 --> 22:39types that you can actually take?
  • 22:42 --> 22:43Absolutely.
  • 22:43 --> 22:46For patients who have chronic transfusions,
  • 22:46 --> 22:48they're a variety of risks that
  • 22:48 --> 22:50come along with that.
  • 22:50 --> 22:51There's obviously a clear benefit
  • 22:51 --> 22:53in that it keeps you safe
  • 22:53 --> 22:54and protects you against stroke
  • 22:54 --> 22:56and may decrease your pain.
  • 22:56 --> 22:57But you're absolutely right,
  • 22:57 --> 22:58our bodies recognize
  • 22:58 --> 23:00things that aren't foreign,
  • 23:00 --> 23:03and that's why we really work in tandem
  • 23:03 --> 23:05and together with our transfusion
  • 23:05 --> 23:06medicine colleagues to do extended
  • 23:06 --> 23:08typing in patients with sickle cell
  • 23:08 --> 23:10disease to prevent that risk of
  • 23:10 --> 23:12developing antibodies.
  • 23:14 --> 23:16Another big risk is something
  • 23:16 --> 23:17called iron overload,
  • 23:17 --> 23:19where excess iron from the blood deposits
  • 23:19 --> 23:22in different organs like your liver,
  • 23:22 --> 23:23your heart, or your eyes.
  • 23:23 --> 23:26So we measure that regularly and again,
  • 23:26 --> 23:28medicine is so cool because we're
  • 23:28 --> 23:30always ideally moving forward and
  • 23:30 --> 23:33there's also a procedure
  • 23:33 --> 23:35called Erythrocytosis
  • 23:35 --> 23:36which I don't too much mind
  • 23:36 --> 23:37saying five times fast,
  • 23:37 --> 23:40but I like it, which can help
  • 23:40 --> 23:41decrease that risk of iron overload.
  • 23:49 --> 23:50Let's talk a little bit
  • 23:50 --> 23:52about some of the exciting advances
  • 23:52 --> 23:55in terms of sickle cell disease.
  • 23:55 --> 23:56Tell us about what you think are the
  • 23:56 --> 23:58most exciting things that are on the
  • 23:58 --> 24:00forefront that you think are really going
  • 24:00 --> 24:01to make a difference for your patients.
  • 24:03 --> 24:06I think there are a lot of
  • 24:06 --> 24:09medications in the works to address pain
  • 24:09 --> 24:12and complications of sickle cell disease.
  • 24:12 --> 24:15But one of the things I think that is
  • 24:15 --> 24:19most exciting is the idea of a cure
  • 24:19 --> 24:22through gene therapy,
  • 24:22 --> 24:23and that's pretty awesome.
  • 24:23 --> 24:27There's been some media, the
  • 24:29 --> 24:32New York Times has published about it
  • 24:32 --> 24:34and the Washington Post as
  • 24:34 --> 24:37well about how we can use different
  • 24:37 --> 24:38scientific technologies like CRISPR
  • 24:38 --> 24:41technology or use different vectors
  • 24:41 --> 24:43like viral vectors to take somebody's
  • 24:43 --> 24:46stem cells and correct that defect
  • 24:46 --> 24:49in their DNA that caused them to
  • 24:49 --> 24:51be making sickle cells and then
  • 24:51 --> 24:54give it back to them in a safe way,
  • 24:54 --> 24:56and then when those new and
  • 24:56 --> 24:57improved cells from their bodies
  • 24:57 --> 24:58replicate
  • 24:58 --> 25:00they are no longer affected
  • 25:00 --> 25:02by sickle cell disease.
  • 25:02 --> 25:04They may still make some sickle cells,
  • 25:04 --> 25:06but will effectively be cured or
  • 25:06 --> 25:08be like somebody who just has the
  • 25:08 --> 25:10trait and that's one of the things
  • 25:10 --> 25:11I think that's most exciting.
  • 25:11 --> 25:13The possibility of a cure
  • 25:13 --> 25:15in our future.
  • 25:18 --> 25:21And is that 10-15, 30-50 years from now?
  • 25:21 --> 25:23No, the time is totally now,
  • 25:23 --> 25:25so there are clinical,
  • 25:25 --> 25:27active clinical trials going on
  • 25:27 --> 25:29to better understand the safety
  • 25:29 --> 25:32and efficacy of this process
  • 25:32 --> 25:34for patients and so
  • 25:34 --> 25:36that's happening now.
  • 25:36 --> 25:38Wow, that's
  • 25:38 --> 25:41super exciting. What else is going on?
  • 25:42 --> 25:45So I think the other main things are
  • 25:45 --> 25:47the development of oral medications
  • 25:47 --> 25:49to improve pain and to decrease
  • 25:49 --> 25:51complications from sickle cell disease.
  • 25:51 --> 25:53That one medication,
  • 25:53 --> 25:56Adakveo, the way that it works,
  • 25:56 --> 25:57it's something called
  • 25:57 --> 25:58a B selection inhibitor.
  • 25:58 --> 26:00And so they're more medications
  • 26:00 --> 26:03coming around that look at that.
  • 26:03 --> 26:06And there's some additional
  • 26:06 --> 26:09oral medications coming that target
  • 26:09 --> 26:12different mechanisms and other blood
  • 26:12 --> 26:14problems like thalassemia and
  • 26:14 --> 26:16they want to see if those medications
  • 26:16 --> 26:18can work well in
  • 26:18 --> 26:20patients with sickle cell disease.
  • 26:20 --> 26:22So I think that fact that we are shining
  • 26:22 --> 26:24a light on this community of people
  • 26:24 --> 26:27with sickle cell disease and that we as
  • 26:27 --> 26:28a scientific community have committed
  • 26:28 --> 26:31to making their quality of life better,
  • 26:31 --> 26:33that's the thing that's most exciting to me,
  • 26:33 --> 26:36because oftentimes I think my
  • 26:36 --> 26:38patients feel unseen and unheard,
  • 26:38 --> 26:42and so it's great to see so many people,
  • 26:42 --> 26:44brilliant people standing up for them
  • 26:44 --> 26:45and helping to make their lives better.
  • 26:46 --> 26:46That's awesome.
  • 26:46 --> 26:50I guess the last question that I have is
  • 26:50 --> 26:52really with regards to clinical trials.
  • 26:52 --> 26:55I mean, it sounds like there's so
  • 26:55 --> 26:58many great things on the horizon.
  • 26:58 --> 27:01Do you find that young people
  • 27:01 --> 27:04adolescents are interested in clinical
  • 27:04 --> 27:07trials and willing to participate?
  • 27:07 --> 27:10Are there barriers to participation?
  • 27:10 --> 27:11How has that been going along?
  • 27:12 --> 27:14Yeah, so anybody who has lived
  • 27:14 --> 27:16with sickle cell or chronic pain,
  • 27:16 --> 27:18I think is enthusiastic about
  • 27:18 --> 27:21finding a way to have a better
  • 27:21 --> 27:23life and to come have a better
  • 27:23 --> 27:25quality of life and to find a cure.
  • 27:25 --> 27:27When it comes to clinical trials,
  • 27:28 --> 27:31there's a careful balance
  • 27:31 --> 27:33between understanding clinical
  • 27:33 --> 27:36studies and not wanting to feel like
  • 27:36 --> 27:37an experiment and understanding
  • 27:37 --> 27:39how the medical system can wrap
  • 27:39 --> 27:41around you to keep you safe.
  • 27:41 --> 27:43As we understand more about
  • 27:43 --> 27:46how to help you have a cure.
  • 27:46 --> 27:49And so when I think about
  • 27:49 --> 27:50my young people,
  • 27:50 --> 27:52are they interested in clinical trials?
  • 27:52 --> 27:55I think that they have a lot of excellent
  • 27:55 --> 27:57questions about the benefits and
  • 27:57 --> 27:59risks of participating in clinical trials.
  • 27:59 --> 28:01But many of them ultimately,
  • 28:01 --> 28:04when we sit and talk and take the time,
  • 28:04 --> 28:05they understand that it is their
  • 28:05 --> 28:07contribution to not only their health,
  • 28:07 --> 28:09but the community of sickle cell patients.
  • 28:09 --> 28:11And that's the beauty of having providers
  • 28:11 --> 28:13that have known you through the lifespan.
  • 28:13 --> 28:14You have a relationship.
  • 28:14 --> 28:17They know that I care for them.
  • 28:17 --> 28:18They can trust me.
  • 28:18 --> 28:20And so when I offer them this option,
  • 28:23 --> 28:24then there's a little bit
  • 28:24 --> 28:25more willingness to enroll.
  • 28:26 --> 28:29Dr Cece Calhoun is an assistant
  • 28:29 --> 28:31professor of medicine in hematology
  • 28:31 --> 28:32and assistant professor of
  • 28:32 --> 28:34Pediatrics in hematology,
  • 28:34 --> 28:37oncology at the Yale School of Medicine.
  • 28:37 --> 28:38If you have questions,
  • 28:38 --> 28:39the address is canceranswers@yale.edu
  • 28:39 --> 28:42and past editions of
  • 28:42 --> 28:45the program are available in audio and
  • 28:45 --> 28:48written form at yalecancercenter.org.
  • 28:48 --> 28:50We hope you'll join us next week to
  • 28:50 --> 28:52learn more about the fight against
  • 28:52 --> 28:53cancer here on Connecticut Public
  • 28:53 --> 28:55radio funding for Yale Cancer
  • 28:55 --> 28:57Answers is provided by Smilow
  • 28:57 --> 28:59Cancer Hospital and Astra Zeneca.